239 related articles for article (PubMed ID: 30499407)
1. Apicoplast Metabolism: Parasite's Achilles' Heel.
Kadian K; Gupta Y; Singh HV; Kempaiah P; Rawat M
Curr Top Med Chem; 2018; 18(22):1987-1997. PubMed ID: 30499407
[TBL] [Abstract][Full Text] [Related]
2. Determination of the active stereoisomer of the MEP pathway-targeting antimalarial agent MMV008138, and initial structure-activity studies.
Yao ZK; Krai PM; Merino EF; Simpson ME; Slebodnick C; Cassera MB; Carlier PR
Bioorg Med Chem Lett; 2015 Apr; 25(7):1515-9. PubMed ID: 25754494
[TBL] [Abstract][Full Text] [Related]
3. A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis.
Wu W; Herrera Z; Ebert D; Baska K; Cho SH; DeRisi JL; Yeh E
Antimicrob Agents Chemother; 2015 Jan; 59(1):356-64. PubMed ID: 25367906
[TBL] [Abstract][Full Text] [Related]
4. The methylerythritol phosphate pathway is functionally active in all intraerythrocytic stages of Plasmodium falciparum.
Cassera MB; Gozzo FC; D'Alexandri FL; Merino EF; del Portillo HA; Peres VJ; Almeida IC; Eberlin MN; Wunderlich G; Wiesner J; Jomaa H; Kimura EA; Katzin AM
J Biol Chem; 2004 Dec; 279(50):51749-59. PubMed ID: 15452112
[TBL] [Abstract][Full Text] [Related]
5. A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites.
Guggisberg AM; Park J; Edwards RL; Kelly ML; Hodge DM; Tolia NH; Odom AR
Nat Commun; 2014 Jul; 5():4467. PubMed ID: 25058848
[TBL] [Abstract][Full Text] [Related]
6. Methylerythritol phosphate pathway to isoprenoids: kinetic modeling and in silico enzyme inhibitions in Plasmodium falciparum.
Singh VK; Ghosh I
FEBS Lett; 2013 Sep; 587(17):2806-17. PubMed ID: 23816706
[TBL] [Abstract][Full Text] [Related]
7. The non-mevalonate isoprenoid biosynthesis of plants as a test system for new herbicides and drugs against pathogenic bacteria and the malaria parasite.
Lichtenthaler HK; Zeidler J; Schwender J; Müller C
Z Naturforsch C J Biosci; 2000; 55(5-6):305-13. PubMed ID: 10928537
[TBL] [Abstract][Full Text] [Related]
8. Targeting the methyl erythritol phosphate (MEP) pathway for novel antimalarial, antibacterial and herbicidal drug discovery: inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) enzyme.
Singh N; Chevé G; Avery MA; McCurdy CR
Curr Pharm Des; 2007; 13(11):1161-77. PubMed ID: 17430177
[TBL] [Abstract][Full Text] [Related]
9. Effect of fosmidomycin on metabolic and transcript profiles of the methylerythritol phosphate pathway in Plasmodium falciparum.
Cassera MB; Merino EF; Peres VJ; Kimura EA; Wunderlich G; Katzin AM
Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):377-83. PubMed ID: 17568945
[TBL] [Abstract][Full Text] [Related]
10. The methylerythritol phosphate pathway and its significance as a novel drug target.
Testa CA; Brown MJ
Curr Pharm Biotechnol; 2003 Aug; 4(4):248-59. PubMed ID: 14529427
[TBL] [Abstract][Full Text] [Related]
11. The MEP pathway: a new target for the development of herbicides, antibiotics and antimalarial drugs.
Rodríguez-Concepción M
Curr Pharm Des; 2004; 10(19):2391-400. PubMed ID: 15279616
[TBL] [Abstract][Full Text] [Related]
12. Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum.
Howe R; Kelly M; Jimah J; Hodge D; Odom AR
Eukaryot Cell; 2013 Feb; 12(2):215-23. PubMed ID: 23223036
[TBL] [Abstract][Full Text] [Related]
13. Targeting the apicoplast in malaria.
Biddau M; Sheiner L
Biochem Soc Trans; 2019 Aug; 47(4):973-983. PubMed ID: 31383817
[TBL] [Abstract][Full Text] [Related]
14. Disruption of Apicoplast Biogenesis by Chemical Stabilization of an Imported Protein Evades the Delayed-Death Phenotype in Malaria Parasites.
Boucher MJ; Yeh E
mSphere; 2019 Jan; 4(1):. PubMed ID: 30674649
[TBL] [Abstract][Full Text] [Related]
15. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box.
Bowman JD; Merino EF; Brooks CF; Striepen B; Carlier PR; Cassera MB
Antimicrob Agents Chemother; 2014; 58(2):811-9. PubMed ID: 24247137
[TBL] [Abstract][Full Text] [Related]
16. Relict plastidic metabolic process as a potential therapeutic target.
Sharma D; Soni R; Rai P; Sharma B; Bhatt TK
Drug Discov Today; 2018 Jan; 23(1):134-140. PubMed ID: 28987288
[TBL] [Abstract][Full Text] [Related]
17. The methylerythritol phosphate (MEP) pathway for isoprenoid biosynthesis as a target for the development of new drugs against tuberculosis.
Obiol-Pardo C; Rubio-Martinez J; Imperial S
Curr Med Chem; 2011; 18(9):1325-38. PubMed ID: 21366531
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanism of Action of Antimalarial Benzoisothiazolones: Species-Selective Inhibitors of the Plasmodium spp. MEP Pathway enzyme, IspD.
Price KE; Armstrong CM; Imlay LS; Hodge DM; Pidathala C; Roberts NJ; Park J; Mikati M; Sharma R; Lawrenson AS; Tolia NH; Berry NG; O'Neill PM; John AR
Sci Rep; 2016 Nov; 6():36777. PubMed ID: 27857147
[TBL] [Abstract][Full Text] [Related]
19. Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug development.
Chakraborty A
Life Sci; 2016 Aug; 158():104-10. PubMed ID: 27381078
[TBL] [Abstract][Full Text] [Related]
20. Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.
Uddin T; McFadden GI; Goodman CD
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
